The plant Cannabis sativa produces over 140 known cannabinoids. These chemicals generate considerable interest in the medical research community for their possible application to several intractable disease conditions. Recent reports have prompted parents to strongly consider Cannabis products to treat their children with drug resistant epilepsy. Physicians, though, are reluctant to prescribe Cannabis products due to confusion about their regulatory status and limited clinical data supporting their use.
While many states pondered adult-use cannabis legalization this year, only Illinois found success with its Cannabis Regulation and Tax Act (CRTA), which passed the state legislature and earned the governor’s approval this past summer. With 2020 rapidly approaching, many states with failed 2019 legalization efforts may try again, while others have announced plans to put forth their first attempts at policy reform.